Fact sheet: Invesco Global Health Care

Fund information

Fund name
Invesco Global Health Care A USD
Fund company manager
Invesco Global Asset Mgmt Ltd
Fund type
SIB
Fund manager
Mike Yellen
since 01/10/2004
Fund objective
The Fund aims to achieve long term capital growth by investing in shares of healthcare companies throughout the world. For the full objectives and investment policy please consult the current prospectus.
Benchmark
MSCI World Health Care
Investment style
Growth
Investment method
Shares

Performance snapshot

Quick stats

1 Year return

6.37 %

1 Year rank in sector

14/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 467.6 m

FE Risk score

165

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    82.8%
  • Switzerland
    4.9%
  • France
    2.7%
  • Germany
    2.6%
  • Japan
    2.6%
  • Biotechnology/Medical
    47%
  • Pharmaceuticals
    26.6%
  • Health Care
    15%
  • Healthcare & Medical Products
    9.2%
  • Conglomerates
    1.1%
  • US Equities
    82.8%
  • Swiss Equities
    4.9%
  • French Equities
    2.7%
  • German Equities
    2.6%
  • Japanese Equities
    2.6%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund4.15 %8.32 %6.37 %4.25 %63.16 %
Sector2.44 %5.7 %6.98 %21.14 %97.17 %
Rank within sector9 / 3012 / 3014 / 2924 / 2722 / 23
Quartile th2 nd2 nd2 nd4 th4 th

Calendar performance

YTD-20172016201520142013
Fund16.01 %-13.51 %1.02 %19.31 %37.53 %
Sector15.5 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector16 / 2918 / 2925 / 2722 / 2412 / 23
Quartile th3 rd3 rd4 th4 th3 rd

Risk statistics

Alpha-5.67
Beta1.02
Sharpe-0
Volatility16.43
Tracking error4.99
Information ratio-1.13
R-Squared0.91

Price movement

52 week high132.62
52 week low106.49
Current bid price0
Current offer price0
Current mid price130.66

Holdings by region

  • 82.8% USA
  • 4.9% Switzerland
  • 2.7% France
  • 2.6% Germany
  • 2.6% Japan
  • 1.1% Netherlands
  • 1% Brazil
  • 1% UK
  • 0.7% Others
  • 0.6% Money Market

Holdings by sector

  • 47% Biotechnology/Medical
  • 26.6% Pharmaceuticals
  • 15% Health Care
  • 9.2% Healthcare & Medical Products
  • 1.1% Conglomerates
  • 0.6% Money Market
  • 0.5% Food & Drug Retailers

Holdings by asset type

  • 82.8% US Equities
  • 4.9% Swiss Equities
  • 2.7% French Equities
  • 2.6% German Equities
  • 2.6% Japanese Equities
  • 1.1% Dutch Equities
  • 1% Brazilian Equities
  • 1% UK Equities
  • 0.7% International Equities
  • 0.6% Money Market

Individual holdings

  • 6.1% CELGENE CORP
  • 4.8% THERMO FISHER SCIENTIFIC INC
  • 4.2% ALEXION PHARMACEUTICALS INC
  • 4.2% SHIRE PLC
  • 3.4% BIOMARIN PHARMACEUTICAL
  • 3.2% BRISTOL MYERS SQUIBB SA
  • 3% AETNA INC
  • 2.9% LILLY (ELI) & CO
  • 2.9% UNITEDHEALTH GROUP INC
  • 2.8% BIOGEN INC